Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Research output: Contribution to journal › Review › Research › peer-review

  • Gheorghe Andrei Dan
  • Antoni Martinez-Rubio
  • Stefan Agewall
  • Giuseppe Boriani
  • Martin Borggrefe
  • Fiorenzo Gaita
  • Isabelle Van Gelder
  • Bulent Gorenek
  • Juan Carlos Kaski
  • Keld Kjeldsen
  • Gregory Y.H. Lip
  • Bela Merkely
  • Ken Okumura
  • Jonathan P. Piccini
  • Tatjana Potpara
  • Birgitte Klindt Poulsen
  • Magdi Saba
  • Irina Savelieva
  • Juan L. Tamargo
  • Christian Wolpert
  • Christian Sticherling
  • Joachim R. Ehrlich
  • Richard Schilling
  • Nikola Pavlovic
  • Tom De Potter
  • Andrzej Lubinski
  • Svendsen, Jesper Hastrup
  • Keong Ching
  • John Lewis Sapp
  • Carol Chen-Scarabelli
  • Felipe Martinez
  • ESC Scientific Document Group
Original languageEnglish
JournalEuropace
Volume20
Issue number5
Pages (from-to)731-732
Number of pages2
ISSN1099-5129
DOIs
Publication statusPublished - 2018

    Research areas

  • Antiarrhythmic drugs, Arrhythmias, Atrial fibrillation, Bradycardia, EHRA consensus document, Extrasystoles, Pre-excitation, Proarrhythmias, Sudden cardiac death, Supraventricular arrhythmias, Ventricular tachycardia

ID: 215519244